Everolimus-eluting bioresorbablecoronary scaffold in Asian patients; a 2-yearfollow-up

Authors

  • Muhammad Abdul Salam Azad Department of Cardiology, Rawalpindi Institute of Cardiology, Rawalpindi, Pakistan
  • Uzma Gul Department of Cardiology, Rawalpindi Institute of Cardiology, Rawalpindi, Pakistan
  • Asim Javed Department of Cardiology, Rawalpindi Institute of Cardiology, Rawalpindi, Pakistan

DOI:

https://doi.org/10.47391/JPMA.1149

Abstract

Abstract

Indo-Pakistan population has one of the highest risk of coronary artery disease(CAD) in the world.1Percutaneous interventions with the use of stents has been the mainstay of treatment for CAD, evolving from balloon angioplasty to bare metal stents and then to drug eluting stents. However, there are a few drawbacks related to the metal implant in the coronary, leading to the development of bio-resorbable vascular scaffolds(BVS). This case series studies the implantation techniques and 24 month clinical outcome of bioresorbable stent Absorb at Rawalpindi Institute of Cardiology. From November 1, 2013 till June 30, 2018. Fifty patients undergoing angioplasty with Absorb BVS as elective or primary PCI were enrolled. Case selection was at the discretion of the operator. Patients were followed up clinically. Repeat angiogram was conducted if clinically indicated.  Continuous...

 

Published

2020-11-02

Issue

Section

Case Series